CTIS2023-508278-26-01
Recruiting
Phase 1
A phase I clinical trial on combined (neo-)adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent glioblastoma.
Z Brussel0 sites18 target enrollmentDecember 4, 2023
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- glioblastoma
- Sponsor
- Z Brussel
- Enrollment
- 18
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
Phase Ib/II study assessing the neo-adjuvant combination therapy of vinflunine with cisplatin followed by radical cystectomy in patients with muscle-invasive bladder cancerEUCTR2016-000081-33-DEigartis GmbH42
Recruiting
Phase 2
Phase II trial exploring combined neoadjuvant therapy with Pembrolizumab/Lenvatinib and adjuvant Pembrolizumab in patients with surgically resectable Non-Small- Cell Lung Cancer (NSCLC)2024-514821-45-00Medizinische Universitaet Innsbruck33
Recruiting
N/A
A Phase I/II Trial of combined adjuvant therapy with gemcitabine and cisplatin for resected biliary tract cancerResected biliary tract cancerJPRN-UMIN000004359Shinshu University School of Medicine, Surgery33
Completed
Phase 2
A Phase II Study of Neo-adjuvant Combination Therapy of Trastuzumab and Anastrozole for Hormone Receptor-Positive, HER2-Positive Postmenopausal Breast Cancer(WJOG7412B)Hormone receptor-positive, HER2-positive postmenopausal breast cancerJPRN-UMIN000011023West Japan Oncology Group70
Completed
Phase 2
A Phase II study of neoadjuvant combination chemotherapy with TS-1, cisplatin and Paclitaxel (PCS) for resectable advanced gastric cancer.resectable advanced gastric cancerJPRN-UMIN000006674Kinki University Faculty of Medicine20